1. Home
  2. AYTU vs FORD Comparison

AYTU vs FORD Comparison

Compare AYTU & FORD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • FORD
  • Stock Information
  • Founded
  • AYTU N/A
  • FORD 1961
  • Country
  • AYTU United States
  • FORD United States
  • Employees
  • AYTU N/A
  • FORD 100
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • FORD Plastic Products
  • Sector
  • AYTU Health Care
  • FORD Industrials
  • Exchange
  • AYTU Nasdaq
  • FORD Nasdaq
  • Market Cap
  • AYTU 8.3M
  • FORD 8.2M
  • IPO Year
  • AYTU N/A
  • FORD 1995
  • Fundamental
  • Price
  • AYTU $1.78
  • FORD $6.37
  • Analyst Decision
  • AYTU
  • FORD
  • Analyst Count
  • AYTU 0
  • FORD 0
  • Target Price
  • AYTU N/A
  • FORD N/A
  • AVG Volume (30 Days)
  • AYTU 3.7M
  • FORD 20.7K
  • Earning Date
  • AYTU 05-14-2025
  • FORD 05-14-2025
  • Dividend Yield
  • AYTU N/A
  • FORD N/A
  • EPS Growth
  • AYTU N/A
  • FORD N/A
  • EPS
  • AYTU N/A
  • FORD N/A
  • Revenue
  • AYTU $77,691,000.00
  • FORD $27,729,913.00
  • Revenue This Year
  • AYTU N/A
  • FORD N/A
  • Revenue Next Year
  • AYTU $8.14
  • FORD N/A
  • P/E Ratio
  • AYTU $6.70
  • FORD N/A
  • Revenue Growth
  • AYTU N/A
  • FORD 1.17
  • 52 Week Low
  • AYTU $0.95
  • FORD $3.10
  • 52 Week High
  • AYTU $3.23
  • FORD $8.97
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 55.38
  • FORD 42.35
  • Support Level
  • AYTU $1.90
  • FORD $7.29
  • Resistance Level
  • AYTU $2.70
  • FORD $8.05
  • Average True Range (ATR)
  • AYTU 0.20
  • FORD 0.61
  • MACD
  • AYTU -0.01
  • FORD -0.20
  • Stochastic Oscillator
  • AYTU 37.84
  • FORD 0.85

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About FORD Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as tablets, personal computers, barcode Scanners, GPS devices, and others. The company operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment, provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the Design segment.

Share on Social Networks: